Keytruda (pembrolizumab)

pCPA File Number: 21179
Negotiation Status:
Active Negotiation
Indication(s):
renal cell carcinoma
Sponsor/Manufacturer:
Merck Canada Inc.
CADTH Project Number:
pCODR 10185
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable